Results 91 to 100 of about 1,740,297 (285)

Delayed Diagnosis of Acute Rheumatic Fever in a Patient with Multiple Emergency Department Visits

open access: yesCase Reports in Pediatrics, 2018
While the incidence of acute rheumatic fever (ARF) in the United States has declined over the past years, the disease remains one of the causes of severe cardiovascular morbidity in children. The index of suspicion for ARF in health care providers may be
Inna Kaminecki   +3 more
doaj   +1 more source

Recurrent acute rheumatic fever: A forgotten diagnosis?

open access: yes, 2004
The incidence of acute rheumatic fever has seen a dramatic decline over the last 15 to 20 years in most developed countries and treatment of this disease has changed little since.
Barker, Thomas A.   +4 more
core   +1 more source

Increased ischaemia-modified albumin is associated with inflammation in acute rheumatic fever [PDF]

open access: yes, 2014
Introduction: Ischaemia-modified albumin, a novel biochemical marker for tissue ischaemia, was found to be associated with oxidative stress. The purpose of this study was to assess the role of ischaemia-modified albumin in the diagnosis of acute ...
Baysal, Tamer   +4 more
core   +1 more source

Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care

open access: yesPediatric Investigation, EarlyView.
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley   +1 more source

Coréia de Sydenham: estudo clínico-evolutivo de 53 casos. [PDF]

open access: yes, 1988
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Pediatria, Curso de Medicina, Florianópolis ...
Corrêa Neto, Ylmar
core  

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

Rheumatic Heart Disease: Pathophysiology and Management [PDF]

open access: yesZagazig University Medical Journal
Background: Rheumatic heart disease, which is frequently disregarded by the media and decision-makers, is a significant burden in poor nations where it accounts for the majority of youth cardiovascular morbidity and mortality, resulting in around 250,000
Abdel Salam Sherif   +3 more
doaj   +1 more source

Better cardiac care measures for Aboriginal and Torres Strait Islander people: first national report 2015 [PDF]

open access: yes, 2015
Mortality from cardiac conditions for Indigenous Australians decreased by 41% between 1998 and 2012, while access to cardiac care has improved over time.
Australian Institute of Health and Welfare
core  

Case series: Kikuchi‐Fujimoto disease with diagnostic overlap

open access: yesRheumatology &Autoimmunity, EarlyView.
Kikuchi‐Fujimoto disease (KFD) is a rare, self‐limiting necrotizing lymphadenitis that poses significant diagnostic challenges due to its overlap with tuberculosis, systemic lupus erythematosus (SLE), and malignancy. We present four cases highlighting distinct diagnostic complexities: KFD mimicking tuberculosis with concomitant latent TB infection and ...
Ecem Kalemoglu   +6 more
wiley   +1 more source

Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies

open access: yesRheumatology &Autoimmunity, EarlyView.
In this context, infections associated with each biologic and targeted drug are summarized to inform the stratification of RA patients, including the characteristics of the susceptible patients and their concomitant therapy. We aim to provide a benefit‐risk analysis for clinical decision, and vital indications for the prevention of highly correlated ...
Lujing Wang, Jieshi Lin, Jie Qian
wiley   +1 more source

Home - About - Disclaimer - Privacy